section name header

Basic Information

AUTHOR: Fred F. Ferri, MD

Definition

Malabsorption is the diminished intestinal absorption of dietary nutrients. The majority of malabsorption is due to either congenital or acquired defects in the membrane transport system, absorption, and brush border processing in the intestinal epithelium.

Synonym

Maldigestion

ICD-10CM CODES
K90.4Malabsorption due to intolerance, not elsewhere classified
K90.89Other intestinal malabsorption
K90.9Intestinal malabsorption, unspecified
K91.2Postsurgical malabsorption, not elsewhere classified
Epidemiology & Demographics
Predominant Sex & Age

More common in females, with a mean age of 40

Risk Factors

  • Excessive alcohol consumption
  • History of celiac disease
  • History of irritable bowel disease
  • Intestinal surgery
Genetics

HLA-DQ2 present in 95% of celiac disease

Physical Findings & Clinical Presentation

  • Most commonly nonspecific symptoms such as abdominal flatulence and distention are seen.
  • Due to the osmotic load from maldigestion/malabsorption, watery diarrhea may be present. In the case of fat digestive disorder, steatorrhea ensues.
  • Weight loss is very common, but many patients are able to compensate by increased caloric load. Diffuse disease often has much more pronounced weight loss.
  • Chronic protein malabsorption can cause hypoalbuminemia, leading to edema and ascites.
  • Both microcytic and macrocytic anemia can result from micronutrient deficiency (iron/B12). These patients can be pale and present with fatigue.
  • Bleeding disorders from vitamin K deficiency can lead to ecchymosis, melena, and hematuria.
  • Vitamin D deficiency can lead to bone disorders. Secondary hyperparathyroidism can be a presenting feature.
  • Electrolyte and vitamin deficiency can lead to neurologic disorders such as ataxia, weakness, and neuropathy, and may have positive Chvostek or Trousseau sign.
  • Autoimmune disease-specific dermatologic findings such as alopecia, pellagra, erythema nodosum, pyoderma gangrenosum, cheilosis, glossitis, and aphthous ulcers may be present.
  • Cardinal clinical features of specific malabsorptive disorders are summarized in Table 1.

TABLE 1 Cardinal Clinical Features of Specific Malabsorptive Disorders

DisorderCardinal Clinical Features
Adrenal insufficiencySkin darkening, hyponatremia, hyperkalemia
AmyloidosisRenal disease, nephrotic syndrome, cardiomyopathy, neuropathy, carpal tunnel syndrome, macroglossia, hepatosplenomegaly
Bile acid deficiencyIleal resection or disease, liver disease
Carcinoid syndromeFlushing, cardiac murmur
Celiac diseaseVariable symptoms: Dermatitis herpetiformis, alopecia, aphthous mouth ulcers, arthropathy, neurologic symptoms, and (life-threatening) malnutrition; elevated liver biochemical test levels, mild iron deficiency
Crohn diseaseArthritis, aphthous mouth ulcers, episcleritis, uveitis, pyoderma gangrenosum, erythema nodosum, abdominal mass, fistulas, perianal fistulae, primary sclerosing cholangitis (PSC), laboratory signs of inflammation
CFChronic sinopulmonary disease, meconium ileus, distal intestinal obstruction syndrome (DIOS), elevated sweat chloride
Cystinuria, Hartnup diseaseKidney stones, dermatosis
Diabetes mellitusLong history of diabetes and diabetic complications
Disaccharidase deficiencyBloating and cramping, intermittent diarrhea
GI fistulasPrevious intestinal surgery or trauma, Crohn disease
GlucagonomaMigratory necrolytic erythema, enlarged gallbladder
Hyperthyroidism, hypothyroidismSymptoms and signs of thyroid disease
HypogammaglobulinemiaRecurrent infections
Intestinal ischemiaOther ischemic organ manifestations; abdominal pain with eating (chronic mesenteric ischemia)
LymphomaEnlarged mesenteric or retroperitoneal lymph nodes, abdominal mass, abdominal pain, fever
MastocytosisUrticaria pigmentosum, peptic ulcer
Mycobacterium avium complex infectionAIDS
Pancreatic insufficiencyHistory of pancreatitis, abdominal pain, or alcoholism; large-volume fatty, oily stools; passage of orange oil
Parasitic infectionHistory of travel to endemic areas
PBCJaundice, itching
SclerodermaDysphagia, inability to open the mouth widely, Raynaud phenomenon, skin tightening
SIBOPrevious intestinal surgery, motility disorder (scleroderma, pseudo-obstruction), small intestinal diverticula, strictures
Tropical sprueHistory of travel to endemic area
TuberculosisSpecific history of exposure, living in or travel to endemic area, immunosuppression, abdominal mass or intestinal obstruction, ascites
Whipple diseaseLymphadenopathy, fever, arthritis, cerebral symptoms, heart murmur (pulmonary valve), oculomasticatory myorhythmia
ZESPeptic ulcers, diarrhea

AIDS, Acquired immunodeficiency syndrome; CF, cystic fibrosis; GI, gastrointestinal; PBC, primary biliary cholangitis; SIBO, small intestinal bacterial overgrowth; ZES, Zollinger-Ellison syndrome.

From Feldman M et al: Sleisenger and Fordtran’s gastrointestinal and liver disease, ed 10, Philadelphia, 2016, Elsevier.

Etiology

  • Can be congenital or acquired.
  • Disease-specific etiology. Mechanisms of malabsorption, malabsorbed substrates, and representative causes are summarized in Table 2.

TABLE 2 Mechanisms of Malabsorption, Malabsorbed Substrates, and Representative Causes

Pathophysiologic MechanismMalabsorbed Substrate(s)Representative Causes
Maldigestion
Conjugated bile acid deficiencyFat
Fat-soluble vitamins
Calcium
Magnesium
Hepatic parenchymal disease
Biliary obstruction
SIBO with bile acid deconjugation
Ileal bile acid malabsorption
CCK deficiency
Pancreatic insufficiencyFat
Protein
Carbohydrate
Fat-soluble vitamins
Vitamin B12 (cobalamin)
Congenital defects
Chronic pancreatitis
Pancreatic tumors
Inactivation of pancreatic enzymes (e.g., ZES)
Reduced mucosal digestionCarbohydrateCongenital defects
Acquired lactase deficiency
ProteinGeneralized mucosal disease (e.g., celiac disease, Crohn disease)
Intraluminal consumption of nutrientsVitamin B12 (cobalamin)SIBO Helminthic infections (e.g., Diphyllobothrium latum infection)
Malabsorption
Reduced mucosal absorptionFat
Protein
Carbohydrate
Vitamins
Minerals
Congenital transport defects
Generalized mucosal diseases (e.g., celiac disease, Crohn disease)
Previous intestinal resection or bypass
Infections
Intestinal lymphoma
Decreased transport from the intestineFat
Protein
Intestinal lymphangiectasia
Primary
Secondary (e.g., solid tumors, Whipple disease, lymphomas)
Venous stasis (e.g., from heart failure)
Other Mechanisms
Decreased gastric acid and/or intrinsic factor secretionVitamin B12Pernicious anemia
Atrophic gastritis
Previous gastric resection
Decreased gastric mixing and/or rapid gastric emptyingFat
Calcium
Protein
Previous gastric resection
Autonomic neuropathy
Rapid intestinal transitFatAutonomic neuropathy
Hyperthyroidism

CCK, Cholecystokinin; SIBO, small intestinal bacterial overgrowth; ZES, Zollinger-Ellison syndrome.

From Feldman M et al: Sleisenger and Fordtran’s gastrointestinal and liver disease, ed 10, Philadelphia, 2016, Elsevier.

Diagnosis

Differential Diagnosis

  • Crohn disease
  • Celiac disease
  • Hartnup disease
  • Chronic pancreatitis
  • Pancreatic insufficiency
  • Cystic fibrosis
  • Short bowel syndrome
  • Neoplasm
  • Abetalipoproteinemia
  • Lactose intolerance
  • Small intestine bacterial overgrowth
  • Chronic atrophic gastritis
  • Zollinger-Ellison syndrome
  • Chronic cholestasis
  • Cirrhosis
Workup

  • A detailed history including alcohol consumption and surgical history as well as autoimmune disease can help diagnose the underlying disease. It is important to screen for anemia and electrolyte abnormalities due to malabsorption.
  • Table E3 summarizes malabsorptive diseases or conditions in which noninvasive tests can establish malabsorption or provide a diagnosis.

TABLE E3 Malabsorptive Diseases or Conditions in Which Noninvasive Tests Can Establish Malabsorption or Provide a Diagnosis

Disease or ConditionDiagnostic Test(s)Comment(s)
Lactose malabsorptionLactose hydrogen breath test
Lactose tolerance test
Tests do not differentiate between primary and secondary lactose malabsorption.
Incomplete fructose absorptionFructose hydrogen breath test
SIBO14C-D-xylose breath test
Glucose hydrogen breath test
Schilling test with and without antibiotics
A predisposing factor should be sought if the result of any of the tests is positive.
Bile acid malabsorptionSeHCAT test, 14C-TCA testDoes not differentiate between primary and secondary causes.
Exocrine pancreatic insufficiencyQuantitative fecal fat determinationUsed to establish malabsorption in chronic pancreatitis.
Fecal elastase or chymotrypsin, tubeless testsVariable sensitivity and specificity, depending on the type of test and stage of the disease.
Vitamin B12 malabsorptionSchilling testThe test is performed without intrinsic factor and, depending on the result with intrinsic factor, with antibiotics or pancreatic enzymes. Further tests are necessary if SIBO, terminal ileal disease, or pancreatic disease is suspected.

SeHCAT,Selenium-75-homotaurocholic acid test; SIBO, small intestinal bacterial overgrowth; TCA, taurocholic acid.

From Feldman M et al: Sleisenger and Fordtran’s gastrointestinal and liver disease, ed 10, Philadelphia, 2016, Elsevier.

Laboratory Tests

  • CBC, serum iron, vitamin B12, and folate to detect for anemia.
  • Prothrombin time: Elevated prothrombin time can suggest vitamin K deficiency.
  • Fat malabsorption: The gold standard is the 72-h stool elastase or fat collection. More than 6/g day in the stool is pathologic. This test can be cumbersome, so other options are available. Sudan III stain and acid steatocrit tests are qualitative measures of steatorrhea. Serologic testing for celiac disease should be considered as well.
  • Carbohydrate malabsorption: Carbohydrate malabsorption leads to fermentation of the undigested carbohydrates by intestinal bacteria.
  • The urinary D-xylose test for carbohydrate absorption in the small intestine. After loading with D-xylose, urinary D-xylose levels are measured. Low levels suggest intestinal malabsorption.
  • Lactose intolerance can be tested by the lactose tolerance test or the breath test. The lactose tolerance test measures blood glucose after lactose administration. Development of symptoms or inadequate increase in blood sugar is indicative of lactose intolerance. H2/CO2 breath tests using specific forms of carbohydrates can detect malabsorption as well.
  • Protein malabsorption: Protein malabsorption is likely due to small intestinal bacterial overgrowth or protein gastroenteropathies. Alpha-1 antitrypsin clearance or 99mTc-albumin gamma camera scintigraphy may aid in this diagnosis.
  • Pancreatic insufficiency: Fecal elastase and chymotrypsin levels can distinguish from pancreatic and intestinal causes.
  • Vitamin deficiency: It is important to assess serum vitamin B12 and methylmalonic acid levels. Schilling test is rarely used but can be useful in some cases.
  • Bile acid malabsorption: Quantitative stool bile acid measurement is the preferred method of diagnosis. SeHCAT test (selenium homocholic acid taurine test) is another option but less likely used.
  • Bacterial overgrowth: This can be detected with endoscopic jejunal aspirate culture or a less invasive hydrogen breath test.
  • Table 4 summarizes useful laboratory tests for evaluating patients with suspected malabsorption and for establishing possible nutrient deficiencies.

TABLE 4 Useful Laboratory Tests for Patients With Suspected Malabsorption and for Establishing Possible Nutrient Deficiencies

TestComment(s)
Blood Cell Count
Hematocrit, hemoglobinDecreased in iron, vitamin B12, and folate malabsorption or with blood loss
Mean corpuscular hemoglobin or mean corpuscular volumeDecreased in iron malabsorption; increased in folate and vitamin B12 malabsorption
White blood cells, differentialDecreased in vitamin B12 and folate malabsorption; low lymphocyte count in lymphangiectasia
Biochemical Tests (Serum)
TGsDecreased in severe fat malabsorption
CholesterolDecreased in bile acid malabsorption or severe fat malabsorption
AlbuminDecreased in severe malnutrition, lymphangiectasia, protein-losing enteropathy
Alkaline phosphataseIncreased in calcium and vitamin D malabsorption (severe steatorrhea); decreased in zinc deficiency
Calcium, phosphorus, magnesiumDecreased in extensive small intestinal mucosal disease, after extensive intestinal resection, or in vitamin D deficiency
ZincDecreased in extensive small intestinal mucosal disease or intestinal resection
Iron, ferritinDecreased in celiac disease, in other extensive small intestinal mucosal diseases, and with chronic blood loss
Other Serum Tests
Prothrombin timeProlonged in vitamin K malabsorption
β-CaroteneDecreased in fat malabsorption from hepatobiliary or intestinal diseases
ImmunoglobulinsDecreased in lymphangiectasia, diffuse lymphoma
Folic acidDecreased in extensive small intestinal mucosal diseases, with anticonvulsant use, in pregnancy; may be increased in SIBO
Vitamin B12Decreased after gastrectomy, in pernicious anemia, terminal ileal disease, SIBO, and infection with Diphyllobothrium latum
Methylmalonic acidMarkedly elevated in vitamin B12 deficiency
HomocysteineMarkedly elevated in vitamin B12 or folate deficiency
CitrullineMay be decreased in destructive small intestinal mucosal disease or intestinal resection
Stool Tests
FatQualitative or quantitative increase in fat malabsorption
Elastase, chymotrypsinDecreased concentrations and output in exocrine pancreatic insufficiency
pHLess than 5.5 in carbohydrate malabsorption

SIBO, Small intestinal bacterial overgrowth; TGs, thyroglobulins.

From Feldman M et al: Sleisenger and Fordtran’s gastrointestinal and liver disease, ed 10, Philadelphia, 2016, Elsevier.

Imaging Studies

  • Abdominal ultrasound can identify thickened small bowel wall
  • Endoscopy for visualization and biopsy
  • Small bowel follow through
  • Abdominal computed tomography/MRI
  • Endoscopic retrograde cholangiopancreatography/magnetic resonance cholangiopancreatography/endoscopic ultrasound for identification of pancreatic abnormalities
  • Capsule endoscopy

Treatment

Involves identification and treatment of the underlying illness, treatment of diarrhea, and nutritional repletion

Nonpharmacologic Therapy

  • A gluten-free diet in patients with celiac disease. Avoidance of lactose-containing product in lactose intolerance.
  • Avoidance of caffeine and high sugar containing compounds has been found to decrease diarrhea in some cases.
Acute General Rx

  • Control of the underlying disease should be primary goal.
  • It is also essential to control any volume and electrolyte abnormalities that might exist.
Chronic Rx

  • Control of chronic diarrhea with loperamide should be one of the goals in a chronic malabsorptive state.
  • Correction of volume and electrolyte disturbance with oral rehydration therapy should be made a priority.
  • Bile acid conjugates can decrease steatorrhea in some cases.
  • Pancreatic insufficiency is typically treated with a low-fat diet and exogenous pancreatic enzymes.
  • Teduglutide-homolog of GLP-2 has been shown to increase absorptive surface area in short bowel syndrome.
  • Periodic DEXA scans are indicated in chronic malabsorption in the setting of vitamin D deficiency.
  • Oral supplementation with vitamins and minerals is important, sometimes requiring parenteral therapy.
Referral

  • Gastroenterology consultation can help in diagnosis when initial laboratory testing is unclear.
  • Nutrition consultation can help patients with diet modification to alleviate symptoms.

Pearls & Considerations

Comments

  • Malabsorption should be considered a sign of an underlying disease.
  • Treatment should focus on treating the underlying disorder.
  • Nutrient and volume repletion should be priority in any treatment plan of malabsorption.
Related Content

Celiac Disease (Related Key Topic)

Crohn Disease (Related Key Topic)

Cystic Fibrosis (Related Key Topic)

Irritable Bowel Syndrome (Related Key Topic)

Lactose Intolerance (Related Key Topic)

Chronic Pancreatitis (Related Key Topic)

Short Bowel Syndrome (Related Key Topic)

Small Bowel Intestinal Bacterial Overgrowth (Related Key Topic)

Ulcerative Colitis (Related Key Topic)